Cargando…
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers
The notion that menopausal estrogen replacement therapy increases ovarian cancer risk, but only for the two more common types (i.e. serous and endometrioid), while possibly decreasing risk for clear cell tumors, is strongly suggestive of causality. However, whether estradiol (E(2)) is tumorigenic or...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884983/ https://www.ncbi.nlm.nih.gov/pubmed/26797759 http://dx.doi.org/10.18632/oncotarget.6943 |